IL-22 fusion protein Uses, Dosage, Side Effects and more
IL-22 fusion protein is a recombinant IL-22-Fc fusion protein manufactured in Chinese hamster ovary cells that is composed of 2 human interleukin 22 (IL-22) molecules linked to an immunoglobulin constant region (IgG2-Fc). It is being developed by Evive Biotech (previously known as Generon BioMed Inc).
| Trade Name | IL-22 fusion protein |
| Generic | F-652 |
| F-652 Other Names | IL-22 fusion protein |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
How IL-22 fusion protein works
IL-22 fusion protein incorporates human interleukin 22’s (IL-22) natural epithelial cell growth-promoting activity as IL-22 plays critical roles in promoting tissue repair and suppressing bacterial infection. IL-22 fusion protein is currently being investigated against acute graft vs host disease, acute alcoholic hepatitis, inflammatory diseases, organ injuries, eventual fatal organ failures, and COVID-19.
